Skip to main content

Alkaline Phosphatase Isoenzymes

CPT

84075; 84080

Synonyms
  • Fractionated Alkaline Phosphatase
  • Kasahara Isoenzymes
  • Nag Ao Isoenzymes
  • Regan Isoenzymes

Test Details

Methodology

Electrophoresis

Result Turnaround Time

3 - 5 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Test Includes

Relative percentages of liver, bone and intestinal alkaline phosphatase isoenzymes and total alkaline phosphatase

Use

This test is used to evaluate the contribution of the isoforms of ALP from liver, bone and bowel to total ALP and investigate elevations of ALP to determine the tissue of origin.

Special Instructions

State patient's age and sex on the test request form.

Custom Additional Information

Alkaline phosphatase (ALP) is present in a number of tissues including liver, bone, intestine and placenta.1,2 The activity of ALP found in serum is a composite of isoenzymes from those sites and in some circumstances, placental or Regan isoenzymes. Serum ALP is of interest in the diagnosis of two main groups of conditions: hepatobiliary disease and bone disease associated with increased osteoblastic activity. A rise in ALP activity occurs with all forms of cholestasis, particularly with obstructive jaundice. The response of the liver to any form of biliary tree obstruction is to synthesize more ALP. The main site of new enzyme synthesis is the hepatocytes adjacent to the biliary canaliculi. ALP is also elevated in disorders of the skeletal system that involve osteoblast hyperactivity and bone remodeling, such as Paget disease, rickets, osteomalacia, fractures and malignant tumors. Moderate elevation of ALP may be seen in other disorders such as Hodgkin disease, congestive heart failure, ulcerative colitis, regional enteritis and intra-abdominal bacterial infections.

Liver is the isoenzyme most frequently elevated when total ALP levels are elevated. Liver ALP increases in the blood early in liver disease before most other liver function tests show abnormalities. The wide group of conditions leading to increased liver ALP include acute hepatitis, cirrhosis, fatty liver, drug-induced liver disease, obstruction of biliary flow by carcinoma at the head of the pancreas, bile duct stricture, primary biliary cirrhosis and metastatic carcinoma of the liver.

Bone isoenzyme is elevated as a result of increased osteoblastic activity. This isoenzyme is normally elevated in growing children and adults above age 50. The highest total ALP values have been attributed to an increased bone isoenzyme level due to Paget disease or renal rickets. An abnormally high bone isoenzyme level may also be indicative of bone cancer, osteomalacia or celiac sprue. A decreased bone ALP in children may be attributed to cretinism or to hypophosphatasia.

Intestinal alkaline phosphatase is seen normally in the serum of subjects who have B or O blood types, especially after a fatty meal. Pathologically, the band may be present in perforation of the bowel, ulcerative disease of the intestine and faintly in liver cirrhosis. Acute infarction of the intestine will cause a release of intestinal ALP from the mucosa. Large erosive or ulcerative lesions of the stomach, duodenum or other small intestinal areas or colon may result in an elevation of the serum ALP level. The small intestinal lesions associated with malabsorption are associated with an elevation of the serum intestinal ALP level only if there is an erosive or ulcerative mucosal lesion.

Specimen Requirements

Specimen

Serum or plasma (lithium-heparin)

Volume

1.6 mL

Minimum Volume

0.8 mL (Note: This volume does not allow for repeat testing.)

Container

Red-top tube, gel-barrier tube or green-top (lithium-heparin) tube

Collection Instructions

Serum: Separate serum from cells as soon as possible after the blood is allowed to clot. 

Plasma: Centrifuge and transfer separated heparin plasma to a plastic transport tube and label as Li-heparin plasma.

Stability Requirements

TemperaturePeriod
Room temperature7 days
Refrigerate7 days
Frozen3 months
Freeze/thaw cyclesStable x3

Reference Range

Alkaline Phosphatase (IU/L)
AgeMaleFemale
0 to 5 d47–12747–127
6 to 10 d29–242 29–242
11 to 20 d109–357 109–357
21 to 30 d94–494 94–494
1 to 2 m149–539149–539
3 to 6 m131–452131–452
7 to 11 m117–401117–401
12 m to 6 y158–369158–369
7 to 12 y150–409150–409
13 y156–43578–227
14 y114–37564–161
15 y88–27956–134
16 y74–20751–121
17 y63–161 47–113
18 - 20 y51–12542–106
>20 y44–121 44–121
Liver Fraction (IU/L)
AgeMale Female
0 to 6 m7–507–50
7 m to 5 y21–7722–72
6 to 12 y21–6220–57
13 to 17 y16–5218–55
18 to 100 y21–8623–85
Bone Fraction (IU/L)
AgeMaleFemale
0 to 6 m24–47224–472
7 m to 5 y129–82126–281
6 to 12 y135–356135–349
13 to 17 y81–32326–75
18 to 100 y16–5218–57
Intestinal Fraction (IU/L)
AgeMaleFemale
0 to 6 m0–240–24
7 m to 5 y0–190–18
6 to 12 y0–200–20
13 to 17 y0–190–18
18 to 100 y0–140–14

Storage Instructions

Refrigerate at 2°C to 8°C as soon as possible after collection.

Causes for Rejection

Patient not fasting; citrate, oxalate or EDTA anticoagulated plasma

References

Cannalire G, Pilloni S, Esposito S, Biasucci G, Di Franco A, Street ME. Alkaline phosphatase in clinical practice in childhood: Focus on rickets. Front Endocrinol (Lausanne). 2023 Feb 2;14:1111445. PubMed 36817604

Coleman R, Brown J, Terpos E, et al. Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. Cancer Treat Rev. 2008 Nov;34(7):629-639. PubMed 18579314

Fernández-Gordón Sánchez FM, Labrador CG, Mínguez DR, Fernández SA, Milla CC. Persistently elevated alkaline phosphatase without hepatopathy? Literature review. Rev Esp Enferm Dig. 2024 Aug;116(8):447-448. PubMed 37882192

Jassam NJ, Horner J, Marzo-Ortega H, Sinclair M, Barth JH. Transient rise in alkaline phosphatase activity in adults. BMJ Case Rep. 2009:2009:bcr09.2009.2250. PubMed 22140406

Ramasamy I. Persistent Increase in Serum Alkaline Phosphatase in a Patient with Monoclonal Gammopathy of Undefined Significance. Case Rep Hematol. 2020 Jan 31;2020:8406971. PubMed 32082656

Teitelbaum JE, Laskowski A, Barrows FP. Benign transient hyperphosphatasemia in infants and children: a prospective cohort. J Pediatr Endocrinol Metab. 2011;24(5-6):351-353. PubMed 21823535

Verma J, Gorard DA. Persistently elevated alkaline phosphatase. BMJ Case Rep. 2012 Aug 24;2012:bcr2012006768. PubMed 22922932

Footnotes

1. Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014 Jul;29(3):269-278. PubMed 24966474

2. Lowe D, Sanvictores T, Zubair M, John S. Alkaline Phosphatase. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. 2023 Oct 29. PubMed 29083622

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
001637 Alk Phos Isoenzymes 24332-9 001107 Alkaline Phosphatase IU/L 6768-6
001637 Alk Phos Isoenzymes 24332-9 001638 Liver Fraction %: % 15015-1
001637 Alk Phos Isoenzymes 24332-9 001639 Liver Fraction IU/L: IU/L 1779-8
001637 Alk Phos Isoenzymes 24332-9 001640 Bone Fraction %: % 15013-6
001637 Alk Phos Isoenzymes 24332-9 001641 Bone Fraction IU/L: IU/L 1777-2
001637 Alk Phos Isoenzymes 24332-9 001642 Intestinal Frac.%: % 15014-4
001637 Alk Phos Isoenzymes 24332-9 001643 IntestinalFrac.IU/L: IU/L 1778-0
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001107
Result Code NameAlkaline Phosphatase
UofMIU/L
Result LOINC6768-6
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001638
Result Code NameLiver Fraction %:
UofM%
Result LOINC15015-1
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001639
Result Code NameLiver Fraction IU/L:
UofMIU/L
Result LOINC1779-8
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001640
Result Code NameBone Fraction %:
UofM%
Result LOINC15013-6
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001641
Result Code NameBone Fraction IU/L:
UofMIU/L
Result LOINC1777-2
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001642
Result Code NameIntestinal Frac.%:
UofM%
Result LOINC15014-4
Order Code001637
Order Code NameAlk Phos Isoenzymes
Order Loinc24332-9
Result Code001643
Result Code NameIntestinalFrac.IU/L:
UofMIU/L
Result LOINC1778-0
Reflex Table for Intestinal Frac.%:
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 001645 Please Note: 001645 Please Note: N/A
Reflex 1
Order Code001645
Order NamePlease Note:
Result Code001645
Result NamePlease Note:
UofM
Result LOINCN/A